Medistim (MEDI) Stock Overview
Develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for MEDI from our risk checks.
MEDI Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Medistim ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 260.00 |
| 52 Week High | NOK 276.00 |
| 52 Week Low | NOK 130.00 |
| Beta | 1.04 |
| 1 Month Change | 14.04% |
| 3 Month Change | 18.18% |
| 1 Year Change | 52.94% |
| 3 Year Change | 7.88% |
| 5 Year Change | 32.32% |
| Change since IPO | 2,424.27% |
Recent News & Updates
Returns on Capital Paint A Bright Future For Medistim (OB:MEDI)
Oct 24
Medistim ASA (OB:MEDI) Released Earnings Last Week And Analysts Lifted Their Price Target To kr255
Aug 23Recent updates
Returns on Capital Paint A Bright Future For Medistim (OB:MEDI)
Oct 24Medistim ASA (OB:MEDI) Released Earnings Last Week And Analysts Lifted Their Price Target To kr255
Aug 23Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
May 13We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation
May 02There May Be Reason For Hope In Medistim's (OB:MEDI) Disappointing Earnings
Mar 07
Direct Sales In China, Canada, And Sweden Will Improve Market Control
Expansion into direct markets in China, Canada, and Sweden aims for higher growth through better control and margins than distributor sales.Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon
Dec 13Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models
Oct 28Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 19Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 04One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts
Nov 10What Does Medistim ASA's (OB:MEDI) Share Price Indicate?
Dec 14Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?
Sep 06A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)
Jun 14Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75
Apr 21Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year
Mar 31Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are
Mar 05Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 01Shareholder Returns
| MEDI | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | 9.2% | 1.5% | 1.2% |
| 1Y | 52.9% | 1.0% | 5.9% |
Return vs Industry: MEDI exceeded the Norwegian Medical Equipment industry which returned 1% over the past year.
Return vs Market: MEDI exceeded the Norwegian Market which returned 5.9% over the past year.
Price Volatility
| MEDI volatility | |
|---|---|
| MEDI Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in NO Market | 10.7% |
| 10% least volatile stocks in NO Market | 2.3% |
Stable Share Price: MEDI has not had significant price volatility in the past 3 months compared to the Norwegian market.
Volatility Over Time: MEDI's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 154 | Kari Krogstad | www.medistim.com |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.
Medistim ASA Fundamentals Summary
| MEDI fundamental statistics | |
|---|---|
| Market cap | NOK 4.75b |
| Earnings (TTM) | NOK 142.42m |
| Revenue (TTM) | NOK 662.18m |
Is MEDI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDI income statement (TTM) | |
|---|---|
| Revenue | NOK 662.18m |
| Cost of Revenue | NOK 125.63m |
| Gross Profit | NOK 536.55m |
| Other Expenses | NOK 394.12m |
| Earnings | NOK 142.42m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.79 |
| Gross Margin | 81.03% |
| Net Profit Margin | 21.51% |
| Debt/Equity Ratio | 0% |
How did MEDI perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/27 14:28 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medistim ASA is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Danske Bank |
| Simon Larsson | Danske Bank |
| Geir Holom | DNB Carnegie |